Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J T Bigger

Showing results (11-20 of 248) with videos related to

Pageof 25
Sort By:
Cardiovascular Drugs and Therapy|June 1, 1990
Clinical aspects of trial design: what can we expect from the cardiac arrhythmia suppression trial?J T Bigger
Hospital Practice|August 1, 1980
Supraventricular tachycardiaJ T Bigger
Zeitschrift Fur Kardiologie|January 1, 1985
Risk stratification after myocardial infarctionJ T Bigger
The New England Journal of Medicine|June 30, 1994
Diuretic therapy, hypertension, and cardiac arrestJ T Bigger
The New England Journal of Medicine|October 4, 1979
The quinidine-digoxin interaction: what do we know about it?J T Bigger
The American Journal of Medicine|July 1, 1979
New directions and new uses for risk stratification in the posthospital phase of acute myocardial infarctionJ T Bigger
The New England Journal of Medicine|November 27, 1997
Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial InvestigatorsJ T Bigger
The American Journal of Cardiology|October 16, 1987
Current approaches to drug treatment of ventricular arrhythmiasJ T Bigger
Circulation|May 1, 1987
Why patients with congestive heart failure die: arrhythmias and sudden cardiac deathJ T Bigger
The American Journal of Cardiology|February 20, 1990
Cardiac electrophysiologic effects of moricizine hydrochlorideJ T Bigger
Pageof 25

Showing results (11-20 of 248) with videos related to

Sort By:
Pageof 25
Cardiovascular Drugs and Therapy|June 1, 1990
Clinical aspects of trial design: what can we expect from the cardiac arrhythmia suppression trial?J T Bigger
Hospital Practice|August 1, 1980
Supraventricular tachycardiaJ T Bigger
Zeitschrift Fur Kardiologie|January 1, 1985
Risk stratification after myocardial infarctionJ T Bigger
The New England Journal of Medicine|June 30, 1994
Diuretic therapy, hypertension, and cardiac arrestJ T Bigger
The New England Journal of Medicine|October 4, 1979
The quinidine-digoxin interaction: what do we know about it?J T Bigger
The American Journal of Medicine|July 1, 1979
New directions and new uses for risk stratification in the posthospital phase of acute myocardial infarctionJ T Bigger
The New England Journal of Medicine|November 27, 1997
Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial InvestigatorsJ T Bigger
The American Journal of Cardiology|October 16, 1987
Current approaches to drug treatment of ventricular arrhythmiasJ T Bigger
Circulation|May 1, 1987
Why patients with congestive heart failure die: arrhythmias and sudden cardiac deathJ T Bigger
The American Journal of Cardiology|February 20, 1990
Cardiac electrophysiologic effects of moricizine hydrochlorideJ T Bigger
Pageof 25